baber/WOPTO huggingface dataset:
Patent NZ-222748-A (NZ)
Title: Line feed assembly for line trimmer
Inventor: COLLINS I L
IPC: A01D34/416
Filed: 1987-11-30
Abstract: The cutting head assembly of a motor-driven flexible line trimmer (10) has a line feed mechanism which includes a housing member connected to and driven by a drive shaft (28) from the prime mover and having a centrally located cylindrical wall (46) for receiving a compression spring (30). A locking plate and cup member (14) is reciprocably disposed around the cylindrical wall and compresses the spring substantially to its normal running position where it is held in position relative to the housing member by suitable retention structure. A spool (16) is disposed around the cup portion of the locking plate and cup member and unless restrained, is free to rotate relative to the housing member to pay out line through an aperture in the housing member. A cover ring member (18) has a central opening which is coupled to the housing member and holds a ground engaging button member (20) against the lower end of the cup member when both are in the lower, normal running position, yet permits the button member to reciprocate upwardly against the locking plate and cup member to compress the spring when the button member is bumped against the ground. The locking plate and cup member is driven by the housing member while being permitted to reciprocate axially, while the button member is driven by the cover ring member by way of the housing member while also permitting the button member to reciprocate axially. The spool is held against axial reciprocation by the cover member and the housing member in a manner permitting rotation of the spool relative to the housing. The upper and lower faces of the spool have radially extending ribs (84, 88) which cooperate with locking teeth (86) on the lower face of the locking plate and escapement teeth (90) on the upper edge of the button member to lock the spool against rotation when the locking plate and cup member are in the lower, normal running position, and to permit the spool to rotate through a controlled increment when the button is bumped against the ground and thus reciprocated, along with the locking plate member, upwardly then downwardly as a result of the biasing force of the spring.
Patent NZ-223878-A (NZ)
Title: A shaped article suitable for parenteral administration of a somatotropin
Inventor: AZAIN MICHAEL JOSEPH
IPC: A61K9/22
Filed: 1988-03-15
Abstract: Prolonged release administration of somatotropin to a domestic, food-producing animal is provided by the parenteral implantation of a shaped article comprising a solid body of compacted somatotropin which is free of binders and matrix polymers in amounts sufficient to have a substantial effect on release of the somatotropin, and which optionally has a release inhibiting barrier coating covering the article except for at least one uncoated release surface.
Patent NZ-229310-A (NZ)
Title: 4-(quinolin-2-ylmethoxy) phenylacetic acid derivatives and pharmaceutical compositions
Inventor: MOHRS KLAUS
IPC: C07D215/18
Filed: 1989-05-26
Abstract: Substituted 4-(2-quinolinylmethoxy)phenylacetic acid derivatives can be prepared from corresponding 4-(2-quinolinylmethoxy)phenylacetic esters. The compounds can be employed in medicaments.
Patent NZ-233454-A (NZ)
Title: Syringe-implantable transponder: id code modulates transmission derived from frequency division of interrogation signal
Inventor: TAYLOR VERN
IPC: A01K61/00
Filed: 1987-02-25
Abstract: A transponder (32) for transmitting an identification of an animal or the like which is sufficiently miniaturized to be syringe-implantable, thus avoiding the necessity of surgical procedures. The transponder (32) comprises a coil (52) which receives an interrogation signal and transmits an identification signal in response thereto. The transponder (32) receives the energy required for transmission by inductive coupling to an interrogator (12). A single integrated circuit chip (54) is provided which detects the interrogation signal, rectifies it to generate power needed for transmission, stores an identification of the transponder (32) and hence of the animal in which it is implanted, and generates a frequency-shift-keyed, Manchester encoded identification signal in response to the interrogation signal. The device transmits the identification signal in real time, that is, immediately upon commencement of the interrogation signal, such that no discrete elements for energy storage are required.
Patent NZ-237225-A (NZ)
Title: Heterocyclically substituted aminomethylpiperidine derivatives, preparation and pharmaceutical compositions thereof
Inventor: MALEN CHARLES
IPC: A61K31/445
Filed: 1991-02-26
Abstract: Derivatives of general formula (I). 
<IMAGE>
 in which: 
 
  - X denotes a sulphur or oxygen atom or a substituted or unsubstituted amino group, 
  - R denotes a hydrogen atom or any one of the groups A, B, C, D, E, F or G, 
  - R' denotes a hydrogen atom, an alkyl group or any one of the groups A, B, C, D, E or F, with R' = H when R = G,
 or else R and R' form an optionally substituted piperazine ring with the nitrogen atom to which they are attached. 
 
<??>Medications.
Patent NZ-237930-A (NZ)
Title: Wafer for administration of medicaments through the sub-lingual mucosa
Inventor: TOVEY GEOFFREY DAVID
IPC: A61K9/70
Filed: 1991-04-24
Abstract: Pharmaceutical compositions in the form of a wafer for the delivery of medicaments to the sub-lingual mucosa are described.
Patent NZ-241028-A (NZ)
Title: Optical fibre line monitoring arrangement
Inventor: DAWSON JOHN FREDERICK
IPC: H04B10/00
Filed: 1991-12-17
Abstract: PCT No. PCT/GB91/02254 Sec. 371 Date Aug. 30, 1993 Sec. 102(e) Date Aug. 30, 1993 PCT Filed Dec. 17, 1991 PCT Pub. No. WO92/11710 PCT Pub. Date Jul. 9, 1992.A line monitoring arrangement of an optical fibre communications system carrying system data signals includes a test sequence generator, an optical transmitter and a correlator. The generator generates a sequence of test pulses, and the optical transmitter repeatedly launches the sequence of test pulses into a first end of a transmission line forming part of the communications system. The correlator correlates signals received at the first end of the transmission line with the sequence of test pulses to identify returned test pulse sequences. The test pulse sequences and system data signals are superimposed onto the transmission line.
Patent NZ-241666-A (NZ)
Title: Human thrombin receptor protein and production and peptides capable of activating them
Inventor: COUGHLIN SHAUN R
IPC: C07K16/00
Filed: 1992-02-19
Abstract: The DNA encoding the cell surface receptor for thrombin has been cloned and sequenced. The availability of this DNA permits the recombinant production of thrombin receptor which can be produced at cell surfaces and is useful in assay systems both for the detection of thrombin and for the evaluation of candidate thrombin agonists. Further, the elucidation of the structure of the thrombin receptor permits the design of agonist and antagonist compounds which are useful diagnostically and therapeutically. The availability of the thrombin receptor also permits production of antibodies specifically immunoreactive with the receptor per se or with specific regions thereof which are also useful diagnostically or therapeutically.
Patent NZ-242905-A (NZ)
Title: Damage-resistant laminate having a decorative sheet coated with a melamine-formaldehyde resin coating containing abrasion-resistant particles
Inventor: ALBRINCK DONALD JOSEPH
IPC: B44C5/04
Filed: 1992-05-26
Abstract: Damage resistant high pressure decorative laminate having excellent scratch, mar, scrape and abrasion resistance, as well as excellent appearance and cleanability and methods of producing same.
Patent NZ-254213-A (NZ)
Title: Lung ventilation device; the evacuation tube thereof having an open end peripherally sealed to the inflation cuff
Inventor: BRAIN ARCHIBALD IAN JEREMY
IPC: A61M16/04
Filed: 1993-07-21
Abstract: A laryngeal mask airway is described which is fitted with an evacuation or drainage tube which passes through the back of the mask and terminates concentrically within an inflatable-cuff formation at the distal end of the mask. In the case of a laryngeal mask which relies on an inflatable ring to establish a seal around the laryngeal inlet, the inflatable-cuff formation results from sealed passage of the evacuation tube through the distal region of the inflatable ring, the distal end of which is centrally apertured and reentrantly folded into sealed junction with the distal end of the tube. When the mask is inflated, its distal end establishes a cuff, sealing the tube against the upper oesophageal sphincter. In the presently preferred embodiment, an auxiliary inflatable cuff is carried at the back side of the mask and, when inflated, establishes a cushioned reference between the evacuation tube and the posterior wall of the pharynx, enabling more effective sealing of the mask to the laryngeal inlet and of the drainage cuff to the oesophageal sphincter, in the circumstance of negative pressure applied to the evacuation tube.
Patent NZ-273752-A (NZ)
Title: Stabilised prostaglandin e1 lyophilisate using tertiary butanol and lactose carriers
Inventor: TEAGARDEN DIRK L
IPC: A61K9/14
Filed: 1994-09-06
Abstract: PCT No. PCT/US94/09648 Sec. 371 Date Mar. 28, 1996 Sec. 102(e) Date Mar. 28, 1996 PCT Filed Sep. 6, 1994 PCT Pub. No. WO95/11683 PCT Pub. Date May 4, 1995A stable and lyophilized formulation of prostaglandin E-1 made by the process comprising a) dissolving PGE-1 in a solution of lactose and tertiary butyl alcohol wherein said tertiary butyl alcohol is present in an amount of from about 15% to about 33% volume/volume and the ratio of said lactose to PGE-1 is from about 40,000 to 1 to about 10,000 to 1 weight/weight whereby a formulation of PGE-1dispersed in lactose is formed; b) adjusting and maintaining the pH of said formulation from about 3.5 to about 6 with an organic acid buffer; c) freezing said formulation to about -50 DEG  C.; and d) drying said formulation to obtain a moisture content of less than 1% by dry weight and a tertiary butyl alcohol content of less than 3% by dry weight. Preferably, step c) includes after freezing said formulation to about -50 DEG  C., warming to about -25 DEG  C. for about 2 hours then refreezing to about 50 DEG  C. Preferably, the prostaglandin is in an amount of about 25 to 100 ppm in lactose and the pH is maintained at about 4 to 5.
Patent NZ-303523-A (NZ)
Title: Recombinant nucleic acids that encode primate MAdCAMs, proteins and polypeptides thereof and use in treating bowel disease
Inventor: BRISKIN MICHAEL J
IPC: C07K19/00
Filed: 1996-02-12
Abstract: Isolated and/or recombinant nucleic acids that encode primate MAdCAMs, and proteins or polypeptides are disclosed, referred to herein as isolated and/or recombinant primate MAdCAMs. Recombinant nucleic acid constructs, comprising a nucleic acid which encodes a primate MAdCAM of the present invention, a portion thereof, or a variant; to host cells comprising such constructs, useful for the production of recombinant proteins; the use of nucleic acids and/or proteins in assays to identify inhibitors (e.g., antagonists) of primate MAdCAM function; and antibodies reactive with primate MAdCAM. The antibodies which inhibit the binding of leukocytes to MAdCAM are useful in the treatment of individuals, particularly humans, suffering from a disease (e.g., inflammatory bowel disease) associated with leukocyte recruitment to the gastrointestinal tract or other tissues, for example, as a result of binding of leukocytes to cells expressing the molecule MAdCAM (gut-associated endothelium).
Patent NZ-306767-A (NZ)
Title: Method of identifying molecular interactions employing counterselection and at least two hybrid molecules or two hybrid systems
Inventor: VIDAL MARC
IPC: C12Q1/68
Filed: 1996-04-11
Abstract: A method for determining whether a first test protein is capable of interacting with a second test protein is claimed comprising: a)	providing a first population of mating component cells wherein a plurality of the cells of the population contains a first counterselectable reporter gene operably linked to a first DNA binding protein recognition site and a first fusion gene which expresses a first hybrid protein; b)	providing a second population of mating competent cells, wherein a plurality of the cells of the second population contains a second counterselectable reporter gene operably linked to a second DNA binding protein recognition site and a second fusion gene which expresses a second hybrid protein; c)	maintaining the first and second population of mating competent cells independently under conditions such that expression of the selectable/counterselectable reporter gene inhibits the growth of the cells; d)	mixing the first and second population of mating competent cells under conditions conducive to formation of mated cells and e)	detecting expression of a reporter gene as a measure of the ability of the first test protein to interact with the second test protein. The reporter gene of step e) is the first or second reporter gene or another reporter gene included in the first and second mating competent cells or the mating cells and is operably to either the first or second DNA binding protein recognition sites. The first hybrid protein comprises the first test protein covalently bonded to a DNA binding moiety which is capable of specifically binding to the DNA binding protein recognition site. The second hybrid protein comprises the second test protein covalently bonded to a gene activating moiety. Also claimed is a method of determining whether a first test protein is capable of disrupting with a second test protein. A method of determining whether a first test protein is capable of interacting with a second test protein and incapable of interacting with a third test protein is claimed. Also claimed are genetic constructs, which are useful in practising the methods as defined above.
Patent NZ-323390-A (NZ)
Title: Process for the preparation of alkylene glycols
Inventor: VAN KRUCHTEN EUGENE MARIE GODF
IPC: C07C31/20
Filed: 1996-11-22
Abstract: A process is disclosed for preparing an alkylene glycol by reacting an alkylene oxide with water in the presence of a catalyst comprising a polymeric organosiloxane ammonium salt having a silica-like skeleton and comprising units of the general formula (I)    <IMAGE>  (I)  wherein R1 to R4, Y and x are as specified in claim 1. Preferred are the catalysts wherein the anion Y is selected from the group of carboxylates having from 1-20 carbon atoms, hydrogen carbonate, hydrogen sulphite, hydrogen phosphate and metalate. These catalysts exhibit an enhanced selectivity stability.
Patent NZ-329289-A (NZ)
Title: Materials of differing density, typically coal and stones, separated by upflowing water column, with stones moved to dewatering station by high pressure fluid flow near bottom of column
Inventor: MCMILLAN DAVID
IPC: B03B11/00
Filed: 1999-02-18
Abstract: Column 11 has fluid supplied at 13 to allow lower density materials to flow over flume 12 but lower density material to sink to the bottom of column 11.  Extractor 10 has fluid supplied at high pressure near the bottom of column 11 (at location C) so as to move stones etc. along path A to dewatering station 18.  Typically fluid is recirculated through extractor 10 from 28 to a pump (not shown) and on to location C.
Patent NZ-329314-A (NZ)
Title: Hybridoma & method of preparing a monoclonal antibody reactive with hc gp-39, use & treatment of rheumatoid arthritis
Inventor: STEENBAKKERS PETRUS GERARDUS A
IPC: C12R1/91
Filed: 1997-12-03
Abstract: The present invention relates to an efficient method of producing monoclonal antibodies against surface antigens of cells and viruses. The method accommodates for antigens which are present in only relatively small amounts, or antigens of which only very small amounts are available or antigens which easily lose their in vivo conformation. Thus the method according to the invention comprises a series of steps, comprising a step in which B-cells from a mammal injected with surface antigen-comprising material are enriched with respect to the relative number of specific B-cells and a step which comprises a small-scale fusion technique.
Patent NZ-332482-A (NZ)
Title: Human and clam cyclin-selective ubiquitin carrier polypeptides (E2) that are involved in the ubiquitination of cyclins A and B, inhibitors of these E2 polypeptides are included
Inventor: RUDDERMAN JOAN V
IPC: C12N9/00
Filed: 1997-03-31
Abstract: Isolated and purified human and clam ubiquitin carrier peptide  (Ubc) which is involved in the ubiquitination of cyclin A and/or B.  Also disclosed are dominant negative selective inhibitors of Ubc, nucleic acids encoding such polypeptides, antibodies specific for such polypeptides, and methods of their use.
Patent NZ-334130-A (NZ)
Title: A stabilized alkali or alkaline earth metal hypobromite used for water treatment to control microbial fouling in a cooling water system, a sweetwater system, a gas scrubber system; and , an air washer system
Inventor: DALLMIER ANTHONY W
IPC: D06L3/06
Filed: 1998-07-22
Abstract: A method of preventing microfouling on the surfaces of equipment in contact within an industrial water system that comprises adding to the aqueous system an anti-microbiologically effective amount of a stabilised sodium hypobromite solution, the solution having been prepared by the steps of: a) Mixing an aqueous solution of alkali or alkaline earth metal hypochlorite having from about 5 percent to about 70 percent available halogen as chlorine with a water soluble bromide ion source;  b) Allowing the bromide ion source and the alkali or alkaline earth metal hypochlorite to react to form a 0.5 to 30 percent by weight aqueous solution of unstabilised alkali or alkaline earth metal hypobromite;  c) Adding to the unstabilised solution of alkali or alkaline earth metal hypobromite a stabiliser selected from the group consisting of carbonic acids. Hydrogen cyanide, carboxylic acids, amino acids, sulfuric acids, phosphoric acids and boric acids;  d) Recovering a stabilised aqueous alkali or alkaline earth metal hypobromite solution. The preferred stabilisers is selected from the group consisting of urea, thiourea, creatinine, cyanuric acids, alkyl hydantoins, mono- or di-ethanolamine, organic sulfonamides, biuret, sulfamic acid, organic sulfamates and melamine.
Patent NZ-334162-A (NZ)
Title: Fuel composition comprising gasoline and at least one esteramine for reducing engine deposits
Inventor: FARMER ROBERT F
IPC: C10L1/222
Filed: 1997-08-06
Abstract: A fuel composition comprising a major amount of a gasoline and an effective deposit-controlling amount of an additive is described.  The additive consists of at least one estermaine of the formula:  (R1-C(O)O-R2)xNR3yR4z wheren R1 is a hydrocarbon group derived from coco, tallow or hydrogenated tallow acid, x is 2 or 3; y and z are individually selected from 0, 1 or 2; x+y+z=3; R2 is selected from the group consisting of C1-C6 alkylene groups and, -(R5O)nR5- groups wherein each R5 can be the same or different and is independently selected from the group consisting of linear or branched C1-C6 alkylene groups and n is 1 to 60, R3 and R4 can be the same or different and are individually selected from the group consisting of C1-C5 alkyl groups, -(R5O)nH groups wherein R5 and n are as defined above, and -R6NR7R8 groups where R6 is a C1 to C5 linear or branched alkylene group, and R7 and R8 can be the same or different and are individually selected from the group consisting of R3, R4 and (R1-C(O)O-R2)- groups wherein R1, R2, R3 and R4 are as defined above.
Patent NZ-334491-A (NZ)
Title: Pictet-spengler reaction for the synthesis of tetrahydroisoquinolines and related heterocyclic compounds
Inventor: WATSON TIMOTHY JAMES-NORMAN
IPC: C07D221/20
Filed: 1997-08-04
Abstract: A Pictet-spengler reaction process for preparing tetrahydroisoquinolines of the formula 1 where R1 and R2 are each independently C1-3 alkyl or R1 and R2 together form C2-7 alkylene N is 0-2 R3 is hydrogen, halogen, C1-4 alkyl, C1-4 alkoxy, -CF3, -OCF3 and -OH Ts is para-toluensulfonyl By reacting a compound II with a suitable Lewis acid like boron trifluoretherate(BF3.OEt2), aluminum chloride, zinc chloride, magnesium bromide, ferric chloride (FeCl3) in formaldehyde generating solvent.
Patent NZ-335148-A (NZ)
Title: Rolling motion guide device for seismic measurements
Inventor: SHIRAI TAKEKI
IPC: F16C29/06
Filed: 1998-08-27
Abstract: The specification describes a rolling motion guide provided with a track rail (2) provided with load rolling body rolling portions (41, 51, 61) on the top surface and both side surfaces.  The guide further comprises a moving block (3) having a horizontal section (8) and sleeve sections (9, 9), on each of which load rolling body rolling portions (42, 52, 62) are provided to correspond to the load rolling body rolling portions of the track rail (2). A multiplicity of rolling bodies (4, 5, 6) interposed between the load rolling body rolling portions of the track rail and the load rolling body rolling portions of the moving block are also described.  The contact angle forming lines (S2, S3) are inclined downward toward the track rail (2).  The lines (S2, S3) being defined by connecting points of contact between the rolling bodies (5, 6) disposed on the respective sides of the track rail (2) and a pair of the load rolling body rolling portions (51, 52; 61, 62), which interpose between the rolling bodies, in a state where a compressive load acts between the moving block (3) and the track rail (2).
Patent NZ-500624-A (NZ)
Title: Oil from water separator
Inventor: TOLMIE DAVID BLEASDALE
IPC: B01D17/02
Filed: 1998-04-24
Abstract: An oil from water separation system (20) including an oil disengagement chamber (21) in communication with an effluent water chamber (85) from which a volume of effluent water equal to an oil and water accumulation volume (29) is controllably discharged by way of a flow retarding device (26) wherein rate of outflow is a function of the head of the liquid in the effluent water chamber (85). The flow-retarding device can take the form of a siphon pipe (22) or one or more bleed apertures (33, 43).
Patent NZ-500874-A (NZ)
Title: Composition comprising ciclesonide, propellant (1,1,1,2-tetrafluoroethane or 1,1,1,2,3,3,3-heptafluoropropane or a mixture thereof) and ethanol
Inventor: SCOTT JOHN S
IPC: A61K47/06
Filed: 1998-05-18
Abstract: The pharmaceutical composition comprises a therapeutically effective amount of a compound of formula (I), in which: R1 is 1-butyl, 2-butyl, cyclohexyl or phenyl and R2 is acetyl or isobutanoyl, and a propellant selected from 1,1,1,2-tetrafluoroethane, 1,1,1,2,3,3,3-heptafluoropropane and a mixture thereof, and ethanol in an amount effective to solubilise the compound of formula (I) and optionally a surfactant. Also described is a pharmaceutical composition comprising the compound of formula (I), a hydrofluorocarbon propellant and a co-solvent in an amount effective to solubilise the compound of formula (I); in the form of an aerosol and contained in an aerosol canister equipped with a dispensing valve.
Patent NZ-504793-A (NZ)
Title: Complex between carrageenan and a water soluble drug having a specific granulometry and relative controlled release pharmaceutical compositions
Inventor: CARAMELLA CARLA MARCELLA
IPC: A61K47/36
Filed: 1998-10-29
Abstract: A complex between carrageenan and a water soluble drug characterised in powder form having an average particle size comprised between 10 and 100ìm.  The basic water drug is contained in the complex in amounts ranging from 1.5 and 5 mmol/g carrageenan.  Also described is a process for preparing this complex and relative controlled release pharmaceutical compositions containing it.